230 related articles for article (PubMed ID: 27437873)
41. Genetic markers of type 2 diabetes: Progress in genome-wide association studies and clinical application for risk prediction.
Wang X; Strizich G; Hu Y; Wang T; Kaplan RC; Qi Q
J Diabetes; 2016 Jan; 8(1):24-35. PubMed ID: 26119161
[TBL] [Abstract][Full Text] [Related]
42. Genetic susceptibility to type 2 diabetes is associated with reduced prostate cancer risk.
Pierce BL; Ahsan H
Hum Hered; 2010; 69(3):193-201. PubMed ID: 20203524
[TBL] [Abstract][Full Text] [Related]
43. Association of KALRN, ADIPOQ, and FTO gene polymorphism in type 2 diabetic patients with coronary artery disease: possible predisposing markers.
Mofarrah M; Ziaee S; Pilehvar-Soltanahmadi Y; Zarghami F; Boroumand M; Zarghami N
Coron Artery Dis; 2016 Sep; 27(6):490-6. PubMed ID: 27218147
[TBL] [Abstract][Full Text] [Related]
44. Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes.
Gudmundsson J; Sulem P; Steinthorsdottir V; Bergthorsson JT; Thorleifsson G; Manolescu A; Rafnar T; Gudbjartsson D; Agnarsson BA; Baker A; Sigurdsson A; Benediktsdottir KR; Jakobsdottir M; Blondal T; Stacey SN; Helgason A; Gunnarsdottir S; Olafsdottir A; Kristinsson KT; Birgisdottir B; Ghosh S; Thorlacius S; Magnusdottir D; Stefansdottir G; Kristjansson K; Bagger Y; Wilensky RL; Reilly MP; Morris AD; Kimber CH; Adeyemo A; Chen Y; Zhou J; So WY; Tong PC; Ng MC; Hansen T; Andersen G; Borch-Johnsen K; Jorgensen T; Tres A; Fuertes F; Ruiz-Echarri M; Asin L; Saez B; van Boven E; Klaver S; Swinkels DW; Aben KK; Graif T; Cashy J; Suarez BK; van Vierssen Trip O; Frigge ML; Ober C; Hofker MH; Wijmenga C; Christiansen C; Rader DJ; Palmer CN; Rotimi C; Chan JC; Pedersen O; Sigurdsson G; Benediktsson R; Jonsson E; Einarsson GV; Mayordomo JI; Catalona WJ; Kiemeney LA; Barkardottir RB; Gulcher JR; Thorsteinsdottir U; Kong A; Stefansson K
Nat Genet; 2007 Aug; 39(8):977-83. PubMed ID: 17603485
[TBL] [Abstract][Full Text] [Related]
45. A Powerful Procedure for Pathway-Based Meta-analysis Using Summary Statistics Identifies 43 Pathways Associated with Type II Diabetes in European Populations.
Zhang H; Wheeler W; Hyland PL; Yang Y; Shi J; Chatterjee N; Yu K
PLoS Genet; 2016 Jun; 12(6):e1006122. PubMed ID: 27362418
[TBL] [Abstract][Full Text] [Related]
46. Association of genetic variations in TCF7L2, SLC30A8, HHEX, LOC387761, and EXT2 with Type 2 diabetes mellitus in Tunisia.
Kifagi C; Makni K; Boudawara M; Mnif F; Hamza N; Abid M; Granier C; Ayadi H
Genet Test Mol Biomarkers; 2011 Jun; 15(6):399-405. PubMed ID: 21510814
[TBL] [Abstract][Full Text] [Related]
47. A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk.
Dicanio M; Giaccherini M; Clay-Gilmour A; Macauda A; Sainz J; Machiela MJ; Rybicka-Ramos M; Norman AD; Tyczyńska A; Chanock SJ; Barington T; Kumar SK; Bhatti P; Cozen W; Brown EE; Suska A; Haastrup EK; Orlowski RZ; Dudziński M; Garcia-Sanz R; Kruszewski M; Martinez-Lopez J; Beider K; Iskierka-Jazdzewska E; Pelosini M; Berndt SI; Raźny M; Jamroziak K; Rajkumar SV; Jurczyszyn A; Vangsted AJ; Collado PG; Vogel U; Hofmann JN; Petrini M; Butrym A; Slager SL; Ziv E; Subocz E; Giles GG; Andersen NF; Mazur G; Watek M; Lesueur F; Hildebrandt MAT; Zawirska D; Ebbesen LH; Marques H; Gemignani F; Dumontet C; Várkonyi J; Buda G; Nagler A; Druzd-Sitek A; Wu X; Kadar K; Camp NJ; Grzasko N; Waller RG; Vachon C; Canzian F; Campa D
Int J Cancer; 2023 Jan; 152(2):239-248. PubMed ID: 36082445
[TBL] [Abstract][Full Text] [Related]
48. The rs4430796 SNP of the HNF1β gene associates with type 2 diabetes in older adults.
Machado-Silva W; Tonet-Furioso AC; Gomes L; Córdova C; Moraes CF; Nóbrega OT
Rev Assoc Med Bras (1992); 2018 Jul; 64(7):586-589. PubMed ID: 30365659
[TBL] [Abstract][Full Text] [Related]
49. In Vivo Reporter Assays Uncover Changes in Enhancer Activity Caused by Type 2 Diabetes-Associated Single Nucleotide Polymorphisms.
Eufrásio A; Perrod C; Ferreira FJ; Duque M; Galhardo M; Bessa J
Diabetes; 2020 Dec; 69(12):2794-2805. PubMed ID: 32912862
[TBL] [Abstract][Full Text] [Related]
50. A genetic link between type 2 diabetes and prostate cancer.
Frayling TM; Colhoun H; Florez JC
Diabetologia; 2008 Oct; 51(10):1757-60. PubMed ID: 18696045
[TBL] [Abstract][Full Text] [Related]
51. GWAS-Identified Variants for Obesity Do Not Influence the Risk of Developing Multiple Myeloma: A Population-Based Study and Meta-Analysis.
Sánchez-Maldonado JM; Cabrera-Serrano AJ; Chattopadhyay S; Campa D; Garrido MDP; Macauda A; Ter Horst R; Jerez A; Netea MG; Li Y; Hemminki K; Canzian F; Försti A; Sainz J
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047000
[TBL] [Abstract][Full Text] [Related]
52. Genetic predisposition for multiple myeloma.
Pertesi M; Went M; Hansson M; Hemminki K; Houlston RS; Nilsson B
Leukemia; 2020 Mar; 34(3):697-708. PubMed ID: 31913320
[TBL] [Abstract][Full Text] [Related]
53. Pathway-based identification of SNPs predictive of survival.
Pang H; Hauser M; Minvielle S
Eur J Hum Genet; 2011 Jun; 19(6):704-9. PubMed ID: 21368918
[TBL] [Abstract][Full Text] [Related]
54. Search for rare protein altering variants influencing susceptibility to multiple myeloma.
Scales M; Chubb D; Dobbins SE; Johnson DC; Li N; Sternberg MJ; Weinhold N; Stein C; Jackson G; Davies FE; Walker BA; Wardell CP; Houlston RS; Morgan GJ
Oncotarget; 2017 May; 8(22):36203-36210. PubMed ID: 28404951
[TBL] [Abstract][Full Text] [Related]
55. Response to Comment on Dubois-Laforgue et al. Diabetes, Associated Clinical Spectrum, Long-term Prognosis, and Genotype/Phenotype Correlations in 201 Adult Patients With Hepatocyte Nuclear Factor 1B (
Dubois-Laforgue D; Cornu E; Saint-Martin C; Coste J; Bellanné-Chantelot C; Timsit J
Diabetes Care; 2018 Jan; 41(1):e8-e9. PubMed ID: 29263198
[No Abstract] [Full Text] [Related]
56. Genomic variation in myeloma: design, content, and initial application of the Bank On A Cure SNP Panel to detect associations with progression-free survival.
Van Ness B; Ramos C; Haznadar M; Hoering A; Haessler J; Crowley J; Jacobus S; Oken M; Rajkumar V; Greipp P; Barlogie B; Durie B; Katz M; Atluri G; Fang G; Gupta R; Steinbach M; Kumar V; Mushlin R; Johnson D; Morgan G
BMC Med; 2008 Sep; 6():26. PubMed ID: 18778477
[TBL] [Abstract][Full Text] [Related]
57. Risk Alleles for Multiple Myeloma Susceptibility in ADME Genes.
Scionti F; Agapito G; Caracciolo D; Riillo C; Grillone K; Cannataro M; Di Martino MT; Tagliaferri P; Tassone P; Arbitrio M
Cells; 2022 Jan; 11(2):. PubMed ID: 35053305
[TBL] [Abstract][Full Text] [Related]
58. Inherited genetic susceptibility to multiple myeloma.
Morgan GJ; Johnson DC; Weinhold N; Goldschmidt H; Landgren O; Lynch HT; Hemminki K; Houlston RS
Leukemia; 2014 Mar; 28(3):518-24. PubMed ID: 24247655
[TBL] [Abstract][Full Text] [Related]
59. Comment on Dubois-Laforgue et al. Diabetes, Associated Clinical Spectrum, Long-term Prognosis, and Genotype/Phenotype Correlations in 201 Adult Patients With Hepatocyte Nuclear Factor 1B (
Clissold RL; Harries LW; Ellard S; Bingham C; Hattersley AT
Diabetes Care; 2018 Jan; 41(1):e7. PubMed ID: 29263197
[No Abstract] [Full Text] [Related]
60. MyelomA Genetics International Consortium.
Morgan G; Johnsen HE; Goldschmidt H; Palumbo A; Cavo M; Sonneveld P; Miguel JS; Chim CS; Browne P; Einsele H; Waage A; Turesson I; Spencer A; Hajek R; Ludwig H; Hemminki K; Houlston R
Leuk Lymphoma; 2012 May; 53(5):796-800. PubMed ID: 22080755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
